Table 1 The demographic information of the study population
Clinical Indicators | Primary cohort (n = 319) | Validation cohort (n = 96) | P |
|---|---|---|---|
Age | 49(43,56) | 50(44,56) | 0.286 |
BMI | 22.89(21.08,24.75) | 23.28(20.87,25.03) | 0.638 |
Subtypes | 0.361 | ||
SCC | 238(74.6%) | 76(79.2%) | |
AC | 81(25.4%) | 20(20.8%) | |
Menopausal Status | 0.823 | ||
No | 162(50.8%) | 50(52.0%) | |
Yes | 157(49.2%) | 46(48.0%) | |
Clinical Symptoms | 0.444 | ||
Asymptomatic or Other | 69(21.7%) | 25(26.0%) | |
Contact Bleeding | 166(52.0%) | 43(44.8%) | |
Irregular Vaginal Bleeding | 84(26.3%) | 28(29.2%) | |
Smoking History | 0.147 | ||
No | 307(96.2%) | 89(92.7%) | |
Yes | 12(3.8%) | 7(7.3%) | |
Gravidity | 3(2,4) | 3(2,5) | 0.545 |
Parity | 2(1,2) | 2(1,2) | 0.469 |
RBC | 4.06(3.85,4.36) | 4.15(3.92,4.38) | 0.245 |
WBC | 5.46(4.57,6.59) | 5.05(4.35,6.09) | 0.034* |
PLT | 209(174.00,242.00) | 209(170.00,242.00) | 0.566 |
Neutrophil Percentage | 58.0(52.9,63.5) | 54.9(50.9,60.1) | 0.005* |
Lymphocyte Percentage | 31.1(26.3,36.3) | 33.9(29.3,39.1) | 0.004* |
SCCAg | 1.3(0.9,2.5) | 2.0(1.0,2.9) | 0.003* |
CA125 | 14.6(11.0,22.8) | 14.2(10.4,19.2) | 0.369 |
CA19-9 | 10.9(7.4,17.2) | 8.7(6.1,12.9) | 0.005* |
CYFRA 21–1 | 2.4(1.7,3.2) | 2.4(1.9,3.4) | 0.158 |
CEA | 1.8(1.1,2.9) | 1.9(1.3,3.2) | 0.789 |
HPV Subtypes | 0.253 | ||
Low Risk | 233(73.1%) | 78(81.2%) | |
Medium Risk | 16(5.0%) | 4(4.2%) | |
High Risk | 70(21.9%) | 14(14.6%) |